Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bard

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Progress in Lipid Research|January 1, 1991
Pharmacological modulation of ApoA- and ApoB-containing lipoproteinsJ M Bard
Biochemical Society Transactions|August 1, 1993
Triglyceride-rich particles, high-density lipoprotein and their pharmacological modulationJ M Bard, J C Fruchart
Clinical Biochemistry|April 1, 1993
HDL particle measurements: impact for diagnosis and therapyJ M Bard, J C Fruchart
Circulation|April 1, 1993
Heterogeneity of high density lipoprotein particlesJ C Fruchart, G Ailhaud, J M Bard
Diabetes & Metabolism|December 16, 2014
Effect of phytosterols/stanols on LDL concentration and other surrogate markers of cardiovascular riskJ-M Bard, F Paillard, J-M Lecerf
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 14, 1997
Lipoprotein (a) phenotype distribution in a population of bypass patients and its influence on lipoprotein (a) concentrationE Bigot, B Robert, J M Bard, et al.
Diabetes|October 1, 1992
Identification of apoB-containing lipoprotein families in NIDDMP Alaupovic, J M Bard, M Tavella, et al.
Presse Medicale (Paris, France : 1983)|December 3, 1998
[Trends in the measurement of body heights: correlation with lipoparticle LpA1 and insulinemia in the obese]J M Lecerf, M T Fichaux, J M Bard
Klinische Wochenschrift|January 1, 1990
[Determination of blood profile of atherogenic lipids using immunologic techniques]J C Fruchart, J M Bard, V Clavey, et al.
Metabolism: Clinical and Experimental|March 7, 2001
Influence of remnant accumulation markers on plasma concentrations of two lipoprotein(a) subspecies (containing or free of apoE)K Bach-Ngohou, F Giraud, M Krempf, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Progress in Lipid Research|January 1, 1991
Pharmacological modulation of ApoA- and ApoB-containing lipoproteinsJ M Bard
Biochemical Society Transactions|August 1, 1993
Triglyceride-rich particles, high-density lipoprotein and their pharmacological modulationJ M Bard, J C Fruchart
Clinical Biochemistry|April 1, 1993
HDL particle measurements: impact for diagnosis and therapyJ M Bard, J C Fruchart
Circulation|April 1, 1993
Heterogeneity of high density lipoprotein particlesJ C Fruchart, G Ailhaud, J M Bard
Diabetes & Metabolism|December 16, 2014
Effect of phytosterols/stanols on LDL concentration and other surrogate markers of cardiovascular riskJ-M Bard, F Paillard, J-M Lecerf
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 14, 1997
Lipoprotein (a) phenotype distribution in a population of bypass patients and its influence on lipoprotein (a) concentrationE Bigot, B Robert, J M Bard, et al.
Diabetes|October 1, 1992
Identification of apoB-containing lipoprotein families in NIDDMP Alaupovic, J M Bard, M Tavella, et al.
Presse Medicale (Paris, France : 1983)|December 3, 1998
[Trends in the measurement of body heights: correlation with lipoparticle LpA1 and insulinemia in the obese]J M Lecerf, M T Fichaux, J M Bard
Klinische Wochenschrift|January 1, 1990
[Determination of blood profile of atherogenic lipids using immunologic techniques]J C Fruchart, J M Bard, V Clavey, et al.
Metabolism: Clinical and Experimental|March 7, 2001
Influence of remnant accumulation markers on plasma concentrations of two lipoprotein(a) subspecies (containing or free of apoE)K Bach-Ngohou, F Giraud, M Krempf, et al.
Pageof 11